Future Labs, Automation & Technology

Discovery and development of medicines is resource intensive and extremely costly, with an estimated spend of $2.6 billion to bring a new drug to market. Recent reports suggest 70% of Pharma companies anticipate that smart technologies will positively enhance early discovery, R&D and quality operations, improving overall lab efficiency and productivity, and accelerating time-to-market.

However, a combination of strategy, vision, infrastructure, mindset and talent is a prerequisite to drive these types of results and ensure the successful integration and implementation of data-centric, technology-driven, smart labs.

Join technology, service and solution providers in Boston, USA to collaboratively share strategies to facilitate the transition to digitally optimized, connected smart labs of the future.